In Depth 11 Nov 2024
Gene editing sector investment struggles: What’s driving the slowdown?
Find out what is driving the slowdown in gene therapy investment, as the sector continues to struggle with widespread layoffs.
- Latest Posts
Expert Advice 8 Nov 2024
How to negotiate your job offer in biotech
Learn how to be prepared to negotiate your biotech job offer by reading the tips that experts shared with us.
Podcast 8 Nov 2024
How to succeed as a woman in biotech
This week, with Kate Yen, CEO of Auron Therapeutics, we talk about women working as CEOs, or other senior roles, in the biotech space.
In Depth 7 Nov 2024
The biggest private biotech investments in October 2024
The companies Treeline Biosciences, Kailera Therapeutics, and Seaport Therapeutics bagged the biggest private biotech investments in October 2024.
Best in Biotech 7 Nov 2024
Cystic fibrosis: Five biotechs breathing life into the therapeutic space
In this article, we take a look at five biotechs developing potentially transformative medicines to treat this genetic disease.
In Depth 6 Nov 2024
Tuberculosis research: Are we finally close to developing a more effective treatment option?
Learn more about the positive advancements that have been made in tuberculosis research in an attempt to find new treatment options.
ADVERTISEMENT
ADVERTISEMENT
In Depth 5 Nov 2024
From consumer health to pure biopharma: Inside Sanofi’s strategic shift
Delve into Sanofi’s “play to win” strategy as investments are ramping up after their consumer health division’s divestment.
Unlocking AAV gene therapy potential: The role of successful characterization
Explore the role and challenges of AAV characterization, the significance of capsid filling, and the best methods to enhance gene therapy.
News and Trends 4 Nov 2024
Top biotech deals of October 2024
Discover the major biotech partnerships, collaborations and mergers and acquisitions that made headlines in October 2024.
In Depth 1 Nov 2024
Can AI cure Alzheimer’s disease?
A couple of weeks back, we took a look at how artificial intelligence (AI) has had a transformative impact on cancer research. Today, we take a look at how AI tools help tackle another formidable challenge of modern biotech, Alzheimer’s disease. “Alzheimer’s is an incredibly complex disease with numerous factors at play. You have the […]
Podcast 1 Nov 2024
The immunometabolism landscape
To talk about immunometabolism, our guest on the podcast this week is CEO of Sitryx Therapeutics, Iain Kilty.
News and Trends 31 Oct 2024
Halloween biotech stories: Unveiling scientists’ worst fears
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
ADVERTISEMENT
